NeoPhore
Developer of small molecule therapies to treat cancer. The therapies target genetic mechanisms to create neoantigen which stimulates the immune system. The company engages in the inactivation of the DNA mismatch repair (MMR) gene which promotes neoantigen creation and provides immunity against numerous cancers. The company was founded in 2017 and headquartered in Cambridge, United Kingdom. It has raised $44.6M in…
Funding snapshot
About
Developer of small molecule therapies to treat cancer. The therapies target genetic mechanisms to create neoantigen which stimulates the immune system. The company engages in the inactivation of the DNA mismatch repair (MMR) gene which promotes neoantigen creation and provides immunity against numerous cancers. The company was founded in 2017 and headquartered in Cambridge, United Kingdom. It has raised $44.6M in series b funding, with backing from Claris Ventures, Astellas Venture Management, 3B Future Health Fund, 2Invest, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Oncology space. Its offerings span Oncology - Drugs - Pan Cancer and Genomics - Genomics Research - Biomarker Discovery.
Business model
Oncology > Drugs > Pan Cancer,
Genomics > Genomics Research > Biomarker Discovery
Team background
College Wise > Harvard University
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.